Year: 2012


Feb 26 2012

Ear treatment co Otic Pharma raises $4.3m from Orbimed

Otic Pharma is developing foam-based drugs for ear infections for children and dogs. OrbiMed Advisors LLC has invested $4.3 million in Otic Pharma Ltd., which is developing treatments for diseases of the ear. The company’s treatments are based on foam, called “Foam-Otic”, rather than drops. Foam-delivery is better than drops, because foams stay in place […]